HCPCS Code Descriptor:
Injection, luspatercept-aamt, 0.25 mg
Route of Administration:
Potential NDC Listing Errors:
Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.
REBLOZYL is an Anti-Anemia drug manufactured by Celgene and administered via the Subcutaneous route of administration. The J Code: J0896 is aligned to the drug REBLOZYL.
Access Pricing and More By Registering
HCPCS Added Date:
HCPCS Effective Date:
HCPCS Short Description:
Inj luspatercept-aamt 0.25mg
Billing and Coding Guide: